Sign in

Neil Floch MD FACS FASMBS DABOM

@neilflochmd.bsky.social
2K followers 2.9K following 156 posts

Bariatric and Foregut Surgeon passionate about educating and advocating about obesity causes and treatments including medications and bariatric surgery - Associate Professor of Surgery Yale School of Medicine and a self-taught artist - Tufts Graduate

PostsRepliesMedia
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 24/01/2026
American Society for Metabolic and Bariatric Surgery systematic review of literature surrounding support groups and metabolic and bariatric surgery - Surgery for Obesity and Related Diseases www.soard.org/article/S155...
soard.org
American Society for Metabolic and Bariatric Surgery systematic review of literature surrounding support groups and metabolic and bariatric surgery
Patients seeking metabolic and bariatric surgery (MBS) are treated by an interdisciplinary team of surgeons and integrated health professionals before and after their surgery. Support groups are requi...
050
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 04/11/2025
American Society for Metabolic and Bariatric Surgery review of the body mass index #obesity #bariatricsurgery #SOARD www.soard.org/article/S155...
soard.org
American Society for Metabolic and Bariatric Surgery review of the body mass index
The body mass index was first described almost 200 years ago and has since been used as a measure of obesity. This review describes the history, advantages, disadvantages, and alternatives to the body...
0100
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 03/11/2025
Intussusception is a condition or complication where one part of the intestine telescopes into another. It can occur from a mass of the bowel such as a polyp or growth or from fixed point such as in bowel or gastric bypass surgery. #obesity #pediatric surgery #gastricbypass
080
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 18/10/2025
The Yale Obesity Symposium A one-day 7 CME event November 21 2025 NEW developments in Obesity Treatment Speakers including: Lee Kaplan MD PhD Ania Jastreboff MD PhD John Morton MD Register NOW! cme.edu @Yale @YaleMed @YaleSurgery Obesity GLP-1ra Semaglutide Tirzepatide Retatrutide GLP1
230
Reposted by Neil Floch MD FACS FASMBS DABOM
FOGOLF, FOLLOW GOLF @fogolf.bsky.social · 30/04/2025
I lost 160 pounds, here is a side by side comparison of my swing www.fogolf.com/952118/i-lost-160-po… I had gastric bypass surgery in June of 2024, I had quit golf completely and sold my clubs because I thought I wouldn’t be able to play …
fogolf.com
I lost 160 pounds, here is a side by side comparison of my swing
I had gastric bypass surgery in June of 2024, I had quit golf completely and sold my clubs because I thought I wouldn’t be able to play again. by naughtyasf143
131
Reposted by Neil Floch MD FACS FASMBS DABOM
Nature Reviews Endocrinology @natrevendo.nature.com · 12/08/2025
From our September issue: Bile acids in the crosshairs for hypoglycaemia after gastric bypass, a News & Views from Marzieh Salehi (£) bit.ly/3H6tHhG #EndoSky #MedSky
Figure showing enterohepatic circulation of bile acids.
111
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 04/09/2025
onlinelibrary.wiley.com/doi/10.1002/...
onlinelibrary.wiley.com
Tirzepatide Associated With Improved Health‐Related Quality of Life in Adults With Obesity or Overweight in SURMOUNT‐4
Objective In SURMOUNT-4, participants with obesity or overweight regained substantial weight after tirzepatide withdrawal, whereas continued treatment resulted in additional weight reduction. We eva.....
020
Reposted by Neil Floch MD FACS FASMBS DABOM
Demetre Daskalakis @drdemetre.bsky.social · 28/08/2025
Enough is enough. The health of the country is in danger. Read our resignation letters: insidemedicine.substack.com/p/breaking-n...
insidemedicine.substack.com
Breaking News: Read three top CDC officials' resignation emails.
The end of an era.
27952262391
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 26/08/2025
Revisional Bariatric Surgery in The Elderly: A Comprehensive Review of the Safety and Efficacy Profile - Surgery for Obesity and Related Diseases www.soard.org/article/S155... #SOARD #bariatricsurgery #obesity
soard.org
Revisional Bariatric Surgery in The Elderly: A Comprehensive Review of the Safety and Efficacy Profile
Despite the well-known safety and efficacy of metabolic and bariatric surgery (MBS), certain patients require revisional bariatric surgery (RBS) due to weight-related and/or procedure-related complica...
260
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 12/08/2025
The Impact of Bariatric Surgery on Cardiovascular Risk Factors and Outcomes: A Systematic Review | Cureus x.com/neilflochmd/...
x.com
000
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 12/08/2025
Effect of food environment on weight loss after bariatric surgery - Surgery for Obesity and Related Diseases #SOARD #bariatricsurgery #obesity x.com/soard_journa...
x.com
SOARD Journal on X: "Effect of food environment on weight loss after bariatric surgery - Surgery for Obesity and Related Diseases #SOARD #bariatricsurgery #obesity https://t.co/THiNjGTHAR" / X
Effect of food environment on weight loss after bariatric surgery - Surgery for Obesity and Related Diseases #SOARD #bariatricsurgery #obesity https://t.co/THiNjGTHAR
010
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 12/08/2025
x.com/neilflochmd/...
x.com
Neil Floch MD on X: "Effect of Bariatric Surgery on Non-alcoholic Fatty Liver Disease: An Exploratory Metabolomics and Validation Study | Obesity Surgery https://t.co/muF9lrejTk" / X
Effect of Bariatric Surgery on Non-alcoholic Fatty Liver Disease: An Exploratory Metabolomics and Validation Study | Obesity Surgery https://t.co/muF9lrejTk
000
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 21/07/2025
Single-anastomosis duodenal-ileal bypass with sleeve gastrectomy for diabetes: predictors of remission and metabolic outcomes in a multicenter study - Surgery for Obesity and Related Diseases www.soard.org/article/S155...
soard.org
Single-anastomosis duodenal-ileal bypass with sleeve gastrectomy for diabetes: predictors of remission and metabolic outcomes in a multicenter study
The single-anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S) combines the restrictive aspects of a sleeve gastrectomy (SG) with the hypoabsorptive advantages of a gastric bypass. SADI...
000
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 23/04/2025
GLP-1 receptor agonists and the risk of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy: a single-center, retrospective cohort study - Surgery for Obesity and Related Diseases www.soard.org/article/S155...
soard.org
GLP-1 receptor agonists and the risk of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy: a single-center, retrospective cohort study
Whether preoperative exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with postoperative nausea and vomiting (PONV) after laparoscopic sleeve gastrectomy (LSG) remains ...
000
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 20/04/2025
Weight stigma asa barrier to care www.medscape.com/viewarticle/...
medscape.com
Weight Stigma Remains a Barrier to Patient Care
Patients with obesity often report being shamed and stigmatized in medical settings. How can physicians address weight sensitively?
030
Reposted by Neil Floch MD FACS FASMBS DABOM
GoggleDocs @goggledocs.bsky.social · 21/03/2025
Oral semaglutide cost-effective vs. liraglutide—even at 50% ⤵️ price 🔹 🇬🇧 modelled data: ⤴️ QALYs (+0.18) & ⤵️ comp. 🔸 💊 = ⤵️ Rx burden vs. daily 💉 🔹 Results robust across sensitivity analyses ⚠️ funded by NovoNordisk 👉 Challenges low-cost liraglutide, supports 🎯 oral GLP-1 use 🔗 ggdocs.co/9h0bz1
011
Reposted by Neil Floch MD FACS FASMBS DABOM
GoggleDocs @goggledocs.bsky.social · 22/03/2025
📢 #GLP1 ⤵️ kidney decline, CV events & mortality in CKD❗️ 🔹 Meta-analysis of 18K pts w/ eGFR <60: ⤵️ eGFR decline ≥50% (OR 0.72) ⤵️ 💔 (OR 0.86) ⤵️ ☠️ (OR 0.77) 🔸 ⤵️⤵️ with human GLP-1 backbone 🥇Evidence across CKD stages—not just macroalbuminuria 👉 GLP-1 now a key 🎯 in CKD + #T2D 🔗 ggdocs.co/tnqomz
011
Reposted by Neil Floch MD FACS FASMBS DABOM
Prof Derek Connolly @profderekconnolly.bsky.social · 22/03/2025
🌍 Our real-world paper shows GLP1s are associated with lower risk of MACE & less costs than DPP4s or insulin in T2DM at higher CV risk 💔 link.springer.com/article/10.1... @pccs.bsky.social @goggledocs.bsky.social @sabouretcardio.bsky.social @astonuniversity.bsky.social @swbhnhs.bsky.social
link.springer.com
Real-World Comparisons Between Glucagon-Like Peptide-1 Receptor Agonists and Other Glucose-Lowering Agents in Type 2 Diabetes: Retrospective Analyses of Cardiovascular and Economic Outcomes in England...
Introduction Clinical trials have demonstrated that glucagon-like peptide-1 receptor agonists (GLP-1RAs) reduce the risk of major adverse cardiovascular events (MACE) in adults with type 2 diabetes (T...
042
Reposted by Neil Floch MD FACS FASMBS DABOM
GoggleDocs @goggledocs.bsky.social · 15/04/2025
📢 Danuglipron dropped—can orforglipron still be the “oral GLP-1 that delivers”? 🔹 Pfizer halts danuglipron after liver signal 🔸 Orforglipron P2=HbA1c ⤵️2.1%, Wt ⤵️14.7%, no liver signal 🔹 P3 2025—will it safely deliver? 👉 Small molecule GLP-1: blockbuster or cautionary tale? 🔗 ggdocs.co/5qu8y3
ggdocs.co
021
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 19/04/2025
Stress Eating and the Microbiome Can you treat eating disorders with a #microbiome-friendly diet? www.psychologytoday.com/us/blog/mood...
psychologytoday.com
Stress Eating and the Microbiome
Stress eating changes your gut microbes, which increases stress in a vicious cycle. By fixing your microbiome, you become more resilient, making it easier to gain back control.
020
Reposted by Neil Floch MD FACS FASMBS DABOM
Scott C Anderson @scottcanderson.bsky.social · 18/04/2025
What a fecal microbiota transplant lacks in glamour, it totally makes up for in efficacy. scottcanderson.substack.com/p/a-surprisi...
scottcanderson.substack.com
A Surprising Fix for a Personality-Changing Liver Disease
“Our bodies have a finely tuned, built-in detoxifying system: It's called our liver, and it can detoxify our bodies better than any cleanse or fast.” —Harley Pasternak
151
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 13/04/2025
www.nytimes.com/2025/03/06/w...
nytimes.com
Are Ultraprocessed Foods Addictive?
The question has generated controversy among scientists. Here’s what we know.
020
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 12/04/2025
A message from @OMAsocial past PRESIDENT and #OAC board member @DrAngelaFitch: IT IS TIME for #GLP1 #obesity medication pharmaceutical producers to: #betheHERO #betheHERO! Cut the cost to $299 a month and Increase access to care!
130
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 03/04/2025
Yes people are Success people
010
Reposted by Neil Floch MD FACS FASMBS DABOM
medscape.com @medscape.com · 23/03/2025
As bariatric surgery evolves to make the most of GLP-1 drugs, issues of when and how to use them for best results are a key focus: ms.spr.ly/63320qwot8
Female Surgeon
052
Reposted by Neil Floch MD FACS FASMBS DABOM
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 24/03/2025
There are a lot of errors in this misleading article. For instance… reducing the size of the stomach is only one way in which bariatric surgery works - it also increases GLP-1, PYY, and other gut hormones, reduces Ghrelin, increases blood bile acids, alters the microbiome among other benefits
033
Reposted by Neil Floch MD FACS FASMBS DABOM
GDLeahy @xrciseguy.bsky.social · 24/03/2025
This study found that for people with obesity, diet + exercise is not very effective for losing weight. We need a paradigm shift in how to treat this disease. GLP-1 drugs like semaglutide and bariatric surgery are better options. pmc.ncbi.nlm.nih.gov/articles/PMC...
041
Reposted by Neil Floch MD FACS FASMBS DABOM
The Cut @thecut.com · 26/03/2025
The TikTok star is opening up about her decision to undergo bariatric surgery — and keep it offline until now.
thecut.com
Remi Bader Says Her Weight-Loss-Surgery Recovery Was ‘Brutal’
The TikTok star is opening up about her decision to undergo bariatric surgery — and keep it offline until now.
021
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 30/03/2025
www.sciencedirect.com/science/arti...
sciencedirect.com
Semaglutide and bariatric surgery induce distinct changes in the composition of mouse white adipose tissue
Adipose tissue is a central player in energy balance and glucose homeostasis, expanding in the face of caloric overload in order to store energy safel…
141
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 24/03/2025
There are a lot of errors in this misleading article. For instance… reducing the size of the stomach is only one way in which bariatric surgery works - it also increases GLP-1, PYY, and other gut hormones, reduces Ghrelin, increases blood bile acids, alters the microbiome among other benefits
033
Reposted by Neil Floch MD FACS FASMBS DABOM
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 22/03/2025
Health-Related Quality of Life and Health Utility After Metabolic/Bariatric Surgery Versus Medical/Lifestyle Intervention in Individuals With Type 2 Diabetes and Obesity: The ARMMS-T2D Study | Diabetes Care | American Diabetes Association diabetesjournals.org/care/article...
diabetesjournals.org
Health-Related Quality of Life and Health Utility After Metabolic/Bariatric Surgery Versus Medical/Lifestyle Intervention in Individuals With Type 2 Diabetes and Obesity: The ARMMS-T2D Study
OBJECTIVE. Type 2 diabetes and obesity are associated with reduced health-related quality of life (HRQoL) and health utility (HU), but long-term effects of
033
Reposted by Neil Floch MD FACS FASMBS DABOM
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 22/03/2025
GLP-1s and Bariatric Surgery: Before, After, or Both? www.medscape.com/viewarticle/...
medscape.com
GLP-1s and Bariatric Surgery: Before, After, or Both?
As bariatric surgery evolves to make the most of GLP-1 drugs, issues of when and how to use them for best results are a key focus.
042
Reposted by Neil Floch MD FACS FASMBS DABOM
First for Women Magazine @firstmag.bsky.social · 25/01/2025
With Ozempic and Wegovy dominating the diet discussion over the years, find out what role bariatric surgery plays in an Ozempic-obsessed world and how it might be the more fit solution for many dieters. Plus one woman's surgery success story: bit.ly/3Czv7i9
bit.ly
Bariatric Surgery vs. Ozempic: 1 Woman’s Surgery Success Story
Often covered by insurance and can deliver bigger results than drugs like Ozempic, bariatric surgery might be the right fit for many dieters. It worked for Susan!
032
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 24/03/2025
How are hospitals doing in 2025 medcitynews.com/2025/03/hosp...
medcitynews.com
How Are Hospitals Faring Financially in 2025? - MedCity News
Hospitals started 2025 with a stable financial performance driven by strong patient volumes, but rising costs for drugs, supplies, and services continue to put major pressure on margins.
000
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 22/03/2025
The Patent for GLP-1 in Obesity That No One Cared About - ConscienHealth conscienhealth.org/2025/03/the-...
conscienhealth.org
The Patent for GLP-1 in Obesity That No One Cared About - ConscienHealth
A patent for GLP-1 agonists to treat obesity was deemed to have no commercial value two decades ago. Oh how our biases can mislead us.
030
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 22/03/2025
GLP-1 and Eating Control: New Neurobiology Insights endocrinenews.endocrine.org/glp-1-and-ea...
endocrinenews.endocrine.org
GLP-1 and Eating Control: New Neurobiology Insights - Endocrine News
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have revolutionized weight loss management, and researchers are now exploring how these medications can further transform obesity care and offer ne...
041
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 22/03/2025
Childhood Obesity Body Mass Index and Gut Microbiome: A Cluster Randomized Controlled Pilot Feasibility Study www.liebertpub.com/doi/abs/10.1...
liebertpub.com
Childhood Obesity Body Mass Index and Gut Microbiome: A Cluster Randomized Controlled Pilot Feasibility Study | Childhood Obesity
Background: Prebiotic fiber has been examined as a way to foster gut bacteria less associated with obesity. Tests of prebiotic fiber in reducing obesity have occurred mainly in animals, adults, and Ca...
021
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 22/03/2025
Treating class 2–3 obesity with glucagon‐like peptide‐1 agonists: A 2‐year real‐world cohort study - Abdel‐Bary - Diabetes, Obesity and Metabolism dom-pubs.onlinelibrary.wiley.com/doi/10.1111/...
dom-pubs.onlinelibrary.wiley.com
Treating class 2–3 obesity with glucagon‐like peptide‐1 agonists: A 2‐year real‐world cohort study
Aims Despite excellent weight-loss outcomes in clinical trials, Glucagon-Like Peptide 1 receptor agonists (GLP1RA) face challenges with accessibility and compliance in clinical use. We seek to quant...
000
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 22/03/2025
GLP-1 receptor agonists causing euglycemic ketoacidosis in patients without diabetes: a brief review | International Journal of Obesity www.nature.com/articles/s41...
nature.com
GLP-1 receptor agonists causing euglycemic ketoacidosis in patients without diabetes: a brief review - International Journal of Obesity
International Journal of Obesity - GLP-1 receptor agonists causing euglycemic ketoacidosis in patients without diabetes: a brief review
010
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 22/03/2025
Comparing clinical outcomes of adults with obesity receiving tirzepatide versus bariatric metabolic surgery: A multi-institutional propensity score-matched study dom-pubs.onlinelibrary.wiley.com/doi/10.1111/...
dom-pubs.onlinelibrary.wiley.com
Comparing clinical outcomes of adults with obesity receiving tirzepatide versus bariatric metabolic surgery: A multi‐institutional propensity score‐matched study
Aims This real-world study compared clinical outcomes between tirzepatide treatment and bariatric metabolic surgery (BMS) in adults with obesity. Methods This retrospective cohort study used the T.....
000
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 22/03/2025
Impact of weight loss on obesity‐related complications and direct healthcare costs in Japan: A modelling study - Igarashi - Diabetes, Obesity and Metabolism dom-pubs.onlinelibrary.wiley.com/doi/10.1111/...
dom-pubs.onlinelibrary.wiley.com
Impact of weight loss on obesity‐related complications and direct healthcare costs in Japan: A modelling study
Aim Body mass index (BMI) in Japan has increased over the past decades, leading to corresponding increases in the risks of complications such as type 2 diabetes (T2D). We modelled the impact of weig...
000
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 22/03/2025
GLP-1s and Bariatric Surgery: Before, After, or Both? www.medscape.com/viewarticle/...
medscape.com
GLP-1s and Bariatric Surgery: Before, After, or Both?
As bariatric surgery evolves to make the most of GLP-1 drugs, issues of when and how to use them for best results are a key focus.
042
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 22/03/2025
Overdiagnosis and Barrett’s oesophagus: a call for clarity | BMJ Evidence-Based Medicine ebm.bmj.com/content/30/2...
ebm.bmj.com
Overdiagnosis and Barrett’s oesophagus: a call for clarity
This paper examines three varied ways in which the notion of overdiagnosis has been employed in literature on Barrett’s oesophagus (BO). It argues that the term has been poorly defined and calls for g...
000
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 22/03/2025
Causal effect of life-course adiposity on the risk of respiratory diseases: a Mendelian randomization study | Nutrition & Metabolism nutritionandmetabolism.biomedcentral.com/articles/10....
nutritionandmetabolism.biomedcentral.com
Causal effect of life-course adiposity on the risk of respiratory diseases: a Mendelian randomization study - Nutrition & Metabolism
Background There is limited evidence on the causal associations of life-course adiposity with the risk of respiratory diseases. This study aimed to elucidate these associations. Methods Two-sample Men...
000
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 22/03/2025
Health-Related Quality of Life and Health Utility After Metabolic/Bariatric Surgery Versus Medical/Lifestyle Intervention in Individuals With Type 2 Diabetes and Obesity: The ARMMS-T2D Study | Diabetes Care | American Diabetes Association diabetesjournals.org/care/article...
diabetesjournals.org
Health-Related Quality of Life and Health Utility After Metabolic/Bariatric Surgery Versus Medical/Lifestyle Intervention in Individuals With Type 2 Diabetes and Obesity: The ARMMS-T2D Study
OBJECTIVE. Type 2 diabetes and obesity are associated with reduced health-related quality of life (HRQoL) and health utility (HU), but long-term effects of
033
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 22/03/2025
The Burden of Diabetes Mortality by County, Race, and Ethnicity in the U.S., 2000–2019 | Diabetes Care | American Diabetes Association diabetesjournals.org/care/article...
diabetesjournals.org
The Burden of Diabetes Mortality by County, Race, and Ethnicity in the U.S., 2000–2019
OBJECTIVE. Diabetes is a leading cause of death in the U.S. Previous studies have found substantial racial, ethnic, and geographical disparities in diabete
000
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 22/03/2025
Real‐world effectiveness of tirzepatide versus semaglutide for weight loss in overweight or obese patients in an ambulatory care setting - Trinh - Diabetes, Obesity and Metabolism dom-pubs.onlinelibrary.wiley.com/doi/10.1111/...
dom-pubs.onlinelibrary.wiley.com
Real‐world effectiveness of tirzepatide versus semaglutide for weight loss in overweight or obese patients in an ambulatory care setting
Click on the article title to read more.
000
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 22/03/2025
nutritionj.biomedcentral.com/articles/10....
nutritionj.biomedcentral.com
Association of the use of nonfood prebiotics, probiotics, and synbiotics with total and cause-specific mortality: a prospective cohort study - Nutrition Journal
Background The use of nonfood prebiotics, probiotics, and synbiotics has approximately tripled in the last 20 years. It is necessary to examine the associations of these substances with all-cause and ...
000
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 19/03/2025
The charade we call HIPAA is fascinating. It is modern medicine’s greatest double standard. We threaten physicians, hospitals, and industry with legal action if they don’t obey it, but… it cannot be enforced. 1/
000
Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 19/03/2025
An effect of #Retatrutide on #Cancer Progression in mice conscienhealth.org/2025/03/an-e...
conscienhealth.org
An Effect of Retatrutide on Cancer Progression in Mice? - ConscienHealth
Intriguing observations on the effect of retatrutide on cancer progression in mice appeared Friday in NPJ Metabolic Health and Disease.
010